Rajesh Gupta1, Ajit Avasthi1, Yogesh K Chawla2, Sandeep Grover1. 1. Department of Psychiatry, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India. 2. Department of Hepatology, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.
Abstract
AIMS: This study aimed to evaluate the prevalence of psychiatric morbidity, fatigue, stigma and quality of life (QOL) of patients with hepatitis B infection. Additional aim of the study was to evaluate the correlates of psychiatric morbidity and QOL in patients with hepatitis B infection. METHODS: A total of 150 patients with hepatitis B virus (HBV) infection (75 inactive carriers and 75 patients with chronic hepatitis) were evaluated on Mini International Neuropsychiatric Interview-PLUS, World Health Organization-QOL-BREF scale, Chronic Liver Disease Questionnaire, Toronto Chinese HBV Stigma Scale, HBV knowledge scale and Fatigue Severity scale. RESULTS: About half of the study participants (49.3%) had at least one lifetime psychiatric morbidity and of these more than one-third (37.3%) fulfilled at least one current psychiatric diagnosis. Generalized anxiety disorder was seen in 19.3% of the participants. Major depressive disorder was the second most common psychiatric diagnosis fulfilled at the time of assessment, with nearly equal prevalence of first episode of depression (8%) and recurrent depressive disorder (7.3%). Compared to those with inactive hepatitis, patients in the chronic hepatitis group had poorer QOL and experienced more fatigue. However, both the groups did not differ in terms of knowledge and stigma. Compared to those without current or lifetime psychiatric diagnosis, those with current or lifetime psychiatric diagnosis had poorer QOL, higher level of stigma and higher fatigue scale. CONCLUSION: About half of the patients with HBV infection have psychiatric morbidity, which has negative impact on QOL of patients. Hence, it is important to recognize psychiatric morbidity among patients with HBV.
AIMS: This study aimed to evaluate the prevalence of psychiatric morbidity, fatigue, stigma and quality of life (QOL) of patients with hepatitis B infection. Additional aim of the study was to evaluate the correlates of psychiatric morbidity and QOL in patients with hepatitis B infection. METHODS: A total of 150 patients with hepatitis B virus (HBV) infection (75 inactive carriers and 75 patients with chronic hepatitis) were evaluated on Mini International Neuropsychiatric Interview-PLUS, World Health Organization-QOL-BREF scale, Chronic Liver Disease Questionnaire, Toronto Chinese HBV Stigma Scale, HBV knowledge scale and Fatigue Severity scale. RESULTS: About half of the study participants (49.3%) had at least one lifetime psychiatric morbidity and of these more than one-third (37.3%) fulfilled at least one current psychiatric diagnosis. Generalized anxiety disorder was seen in 19.3% of the participants. Major depressive disorder was the second most common psychiatric diagnosis fulfilled at the time of assessment, with nearly equal prevalence of first episode of depression (8%) and recurrent depressive disorder (7.3%). Compared to those with inactive hepatitis, patients in the chronic hepatitis group had poorer QOL and experienced more fatigue. However, both the groups did not differ in terms of knowledge and stigma. Compared to those without current or lifetime psychiatric diagnosis, those with current or lifetime psychiatric diagnosis had poorer QOL, higher level of stigma and higher fatigue scale. CONCLUSION: About half of the patients with HBV infection have psychiatric morbidity, which has negative impact on QOL of patients. Hence, it is important to recognize psychiatric morbidity among patients with HBV.
Keywords:
CLDQ, Chronic Liver Disease Questionnaire; GAD, Generalized Anxiety Disorder; HBV infection; MINI-PLUS, Mini International Neuropsychiatric Interview-PLUS; QOL, quality of life; WHO QOL-BREF, World Health Organization-Quality of Life-BREF scale; knowledge; psychiatric morbidity; quality of life; stigma
Authors: I Sibitz; M Amering; A Unger; M E Seyringer; A Bachmann; B Schrank; T Benesch; B Schulze; A Woppmann Journal: Eur Psychiatry Date: 2010-10-30 Impact factor: 5.361
Authors: R C Dickson; R M Wright; M D Bacchetta; S E Bodily; S H Caldwell; C J Driscoll; T L Pruett; M B Ishitani Journal: Clin Transplant Date: 1997-08 Impact factor: 2.863
Authors: Chang Keun Park; Soo Young Park; Eun Soo Kim; Jin Hyung Park; Dong Woo Hyun; Young Mi Yun; Chang Min Jo; Won Young Tak; Young Oh Kweon; Sung Kook Kim; Yong Hwan Choi; Shin Goo Park Journal: Taehan Kan Hakhoe Chi Date: 2003-09
Authors: Adrian R Levy; Kris V Kowdley; Uchenna Iloeje; Eskinder Tafesse; Jayanti Mukherjee; Robert Gish; Natalie Bzowej; Andrew H Briggs Journal: Value Health Date: 2007-12-17 Impact factor: 5.725
Authors: Elegance T P Lam; Cindy L K Lam; C L Lai; M F Yuen; Daniel Y T Fong; Thomas M K So Journal: Health Qual Life Outcomes Date: 2009-06-05 Impact factor: 3.186
Authors: Noman ul Haq; Mohamed Azmi Hassali; Asrul A Shafie; Fahad Saleem; Hisham Aljadhey Journal: Health Qual Life Outcomes Date: 2012-08-06 Impact factor: 3.186